FDA authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 vaccines for use as a booster dose
WASHINGTON, D.C. – On Wednesday, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine to authorize bivalent formulations of the vaccines for use as a single booster dose at least two months following primary or booster vaccination. The bivalent vaccines, which we […]